Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

Clinical trial NCT00676312 · COMPLETED

Trial details

NCT number: NCT00676312
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2008-05-01
Primary completion: 2008-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.